Binding characteristics of a panel of monoclonal antibodies against the ligand binding domain of the human LDLr

Journal of Lipid Research

Volumn 47, Issue 7, 2006, Pages 1399-1405

  Nguyen, Anh T ^a   Hirama, Tomoko ^b   Chauhan, Vinita ^a   MacKenzie, Roger ^b   Milne, Ross ^a,c  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Knockout mice; Low density lipoprotein receptor; Structure function analysis

Indexed keywords

EPITOPE; LOW DENSITY LIPOPROTEIN RECEPTOR; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DISULFIDE BOND; FIBROBLAST; HYBRIDOMA; LIGAND BINDING; MOUSE; NONHUMAN; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS;

EID: 33746048475     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M600130-JLR200     Document Type: Article

References (34)

1. Brown, M. S., and J. L. Goldstein. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science. 232: 34-47.
2. Jeon, H., and S. C. Blacklow. 2005. Structure and physiologic function of the low-density lipoprotein receptor. Annu. Rev. Biochem. 74: 535-562.
3. Jeon, H., W. Y. Meng, J. Takagi, M. J. Eck, T. A. Springer, and S. C. Blacklow. 2001. Implications for familial hypercholesterolemia from the structure of the LDL receptor YWTD-EGF domain pair. Nat. Struct. Biol. 8: 499-504.
4. Rudenko, G., L. Henry, K. Henderson, K. Ichtchenko, M. S. Brown, J. L. Goldstein, and J. Deisenhofer. 2002. Structure of the LDL receptor extracellular domain at endosomal pH. Science. 298: 2353-2358.
5. Blacklow, S. C., and P. S. Kim. 1996. Protein folding and calcium binding defects arising from familial hypercholesterolemia mutations of the LDL receptor. Nat. Struct. Biol. 3: 758-762.
6. Bieri, S., J. T. Djordjevic, N. L. Daly, R. Smith, and P. A. Kroon. 1995. Disulfide bridges of a cysteine-rich repeat of the LDL receptor ligand-binding domain. Biochemistry. 34: 13059-13065.
7. Fass, D., S. C. Blacklow, P. S. Kim, and J. M. Berger. 1997. Molecular basis of familial hypercholesterolaemia from structure of LDL receptor module. Nature. 388: 691-693.
8. Kurniawan, N. D., A. R. Atkins, S. Bieri, C. J. Brown, I. M. Brereton, P. A. Kroon, and R. Smith. 2000. NMR structure of a concatemer of the first and second ligand-binding modules of the human lowdensity lipoprotein receptor. Protein Sci. 9: 1282-1293.
9. Jansens, A., E. van Duijn, and I. Braakman. 2002. Coordinated nonvectorial folding in a newly synthesized multidomain protein. Science. 298: 2401-2403.
10. Esser, V., L. E. Limbird, M. S. Brown, J. L. Goldstein, and D. W. Russell. 1988. Mutational analysis of the ligand binding domain of the low density lipoprotein receptor. J. Biol. Chem. 263: 13282-13290.
11. Russell, D. W., M. S. Brown, and J. L. Goldstein. 1989. Different combinations of cysteine-rich repeats mediate binding of low density lipoprotein receptor to two different proteins. J. Biol. Chem. 264: 21682-21688.
12. Fisher, C., D. Abdul-Aziz, and S. C. Blacklow. 2004. A two-module region of the low-density lipoprotein receptor sufficient for formation of complexes with apolipoprotein E ligands. Biochemistry. 43: 1037-1044.
13. Jeon, H., and G. G. Shipley. 2000. Vesicle-reconstituted low density lipoprotein receptor. Visualization by cryoelectron microscopy. J. Biol. Chem. 275: 30458-30464.
14. Innerarity, T. L. 2002. LDL receptor's b-propeller displaces LDL. Science. 298: 2337-2339.
15. Rudenko, G., and J. Deisenhofer. 2003. The low density lipoprotein receptor: ligands, debates and lore. Curr. Opin. Struct. Biol. 13: 683-689.
16. Beglova, N., H. Jeon, C. Fisher, and S. C. Blacklow. 2004. Cooperation between fixed and low pH-inducible interfaces controls lipoprotein release by the LDL receptor. Mol. Cell. 16: 281-292.
17. Chen, C., and H. Okayama. 1987. High efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7: 2745-2752.
18. Beisiegel, U., W. J. Schneider, J. L. Goldstein, R. G. W. Anderson, and M. S. Brown. 1981. Monoclonal antibodies to the low density lipoprotein receptor as probes for study of receptor-mediated endocytosis and the genetics of familial hypercholesterolemia. J. Biol. Chem. 256: 11923-11931.
19. Ishibashi, S., M. S. Brown, J. L. Goldstein, R. D. Gerard, R. E. Hammer, and J. Herz. 1993. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92: 883-893.
20. Milne, R. W., P. K. Weech, and Y. L. Marcel. 1992. Immunological methods for studying and quantifying lipoproteins and apolipoproteins. In Lipoprotein Analysis: A Practical Approach. C. Converse and E. Skinner, editors. Oxford University Press, Oxford. 61-84.
21. Milne, R. W., R. Theolis, R. B. Verdery, and Y. L. Marcel. 1983. Characterization of monoclonal antibodies against human low density lipoprotein. Arteriosclerosis. 3: 23-30.
22. Beisiegel, U., W. J. Schneider, M. S. Brown, and J. L. Goldstein. 1982. Immunoblot analysis of low density lipoprotein receptors in fibroblasts from subjects with familial hypercholesterolemia. J. Biol. Chem. 257: 13150-13156.
23. Havel, R. J., H. A. Eder, and J. H. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353.
24. Bilheimer, D. W., S. Eisenberg, and R. I. Levy. 1972. The metabolism of very low density lipoprotein proteins. Biochim. Biophys. Acta. 260: 212-221.
25. Milne, R., R. Theolis, R. Maurice, R. J. Pease, P. K. Weech, E. Rassart, J. C. Fruchart, J. Scott, and Y. L. Marcel. 1989. The use of monoclonal antibodies to localize the low density lipoprotein receptor-binding domain of apolipoprotein B. J. Biol. Chem. 264: 19754-19760.
26. 2+ and monoclonal antibodies, but not lipoproteins. J. Biol. Chem. 262: 17443-17449.
27. Marcel, Y. L., P. R. Provost, H. Koa, E. Raffai, N. V. Dac, J. C. Fruchart, and E. Rassart. 1991. The epitopes of apolipoprotein A-I define distinct structural domains including a mobile middle region. J. Biol. Chem. 266: 3644-3653.
28. Hopp, T. P., and K. R. Woods. 1983. A computer program for predicting antigenic determinants. Mol. Immunol. 20: 483-489.
29. Kyte, J., and R. F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157: 105-132.
30. Roy, P., R. Mac, T. Kenzie, X. C. Hirama, P. Jiang, P. Kussie, A. Tall, E. Rassart, and R. Milne. 1996. Structure-function relationships of human cholesteryl ester transfer protein: analysis using monoclonal antibodies. J. Lipid Res. 37: 22-34.
31. Guyard-Dangremont, V., V. Tenekjian, V. Chauhan, S. Walter, P. Roy, E. Rassart, and R. Milne. 1999. Immunochemical evidence that cholesteryl ester transfer protein and bactericidal/permeability-increasing protein share a similar tertiary structure. Protein Sci. 8: 2392-2398.
32. Hogarth, C. A., A. Roy, and D. I. Ebert. 2003. Genomic evidence for the absence of a functional cholesteryl ester transfer protein gene in mice and rats. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 135: 219-229.
33. Zlot, C. H., L. M. Flynn, M. M. Véniant, E. Kim, M. Raabe, S. P. McCormick, P. Ambroziak, L. M. McEvoy, and S. G. Young. 1999. Generation of monoclonal antibodies specific for mouse apolipoprotein B-100 in apolipoprotein B-48-only mice. J. Lipid Res. 40: 76-84.
34. Wang, X. Y., V. Chauhan, A. T. Nguyen, J. Schultz, J. Davignon, S. G. Young, J. Borén, T. L. Innerarity, R. T. Hui, and R. W. Milne. 2003. Immunochemical evidence that human apoB differs when expressed in rodent versus human cells. J. Lipid Res. 44: 547-553.